VIP (Vasoactive Intestinal Peptide)

VIP (Vasoactive Intestinal Peptide) is a 28 amino acid neuropeptide with complex neuroendocrine and immunomodulatory functions. Research explores its anti-inflammatory properties and potential in autoimmune and neurodegenerative conditions.

At a Glance

Summary: Activates VPAC receptors to reduce inflammation, promote regulatory T cells, and provide neuroprotection through multiple neuroendocrine pathways. Mechanisms (reported/proposed across domains): Inflammation / immune • Activates VPAC1 and VPAC2 G-protein coupled receptors, increasing intracellular cAMP levels. • Inhibits production of pro-inflammatory cytokines (TNF-α, IL-6, IL-12)...

Safety Profile

Investigational - Complex Compound

Research Dosing

Dose: 50–200 mcg · Route: Subcutaneous (SC) · Intranasal · Frequency: 2–3× daily (intranasal) · Duration: 4–12 weeks

Categories

  • Research Only
  • Immune Modulation
  • Anti-Inflammatory
  • Neuroprotection
  • Gut Health
  • Autoimmune Research
  • Vasodilation
  • Advanced Users
  • Complex Protocol
  • Not FDA Approved

Related Peptides

The Leading Community for Trusted Peptide Research & Insights

Research summaries, dosing protocols, and community reports for peptides. Built on clinical data and real-world experiences.